Since publication of the third edition in 2004 there have been important advances. Several endocrine disorders, such as feline acromegaly and hyperaldosteronism, have risen in importance. The use of diet and novel insulins in diabetic cats, and new drugs such as trilostane and methimazole, which were briefly mentioned in previous editions are now considered routine. In addition, the genetic risks associated with many disorders have been elucidated.
Carmel T. Mooney (Editor), Mark Peterson (Editor)
Softcover, 304 pp; H: 11.7in; W: 8.3in; 2.1 lbs; 2012